The molecular basis for a polyspecific antibody.

Por Wing, M G
Publicado em 1995

The targeting of T-helper cells and tumourcidal macrophages to a B-cell lymphoma using a PPD-monoclonal antibody heteroconjugate.

Por Montgomery, A M, Wing, M G, Lachmann, P J
Publicado em 1992

A novel strategy for targeting CD4+ PPD-reactive T cells against tumour cells using PPD monoclonal antibody heteroconjugates.

Por Montgomery, A M, Wing, M G, Lachmann, P J
Publicado em 1990

Cytostasis of different tumours by a murine PPD-reactive CD4+ T lymphocyte clone is mediated by interferon-gamma and tumour necrosis factor alone or synergistically.

Por Wing, M G, Montgomery, A M, Harley, C, Lachmann, P J
Publicado em 1990

Oligodendrocytes lack glycolipid anchored proteins which protect them against complement lysis. Restoration of resistance to lysis by incorporation of CD59.

Por Wing, M G, Zajicek, J, Seilly, D J, Compston, D A, Lachmann, P J
Publicado em 1992

A therapeutic human IgG4 monoclonal antibody that depletes target cells in humans

Por ISAACS, J D, WING, M G, GREENWOOD, J D, HAZLEMAN, B L, HALE, G, WALDMANN, H
Publicado em 1996

Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells.

Por Wing, M G, Moreau, T, Greenwood, J, Smith, R M, Hale, G, Isaacs, J, Waldmann, H, Lachmann, P J, Compston, A
Publicado em 1996